Abstract
The inborn errors of GM2 ganglioside metabolism cause GM2 ganglioside to accumulate within the lysosomes of the nerve celis. The majority of the patients are infants with the Tay-Sachs from of the disease associated with a severe deficiency of β-N-Acetylhexosaminidase A (hexosaminidase A). Both Hexosaminidase A and B are deficient in Sandhoff disease.
The serum total hexosaminidase and the percentage of hexosaminidase A and B were estimated in 449 patients who presented with progressive mental-motor retardation. Three cases of Tay-Sachs disease and two cases of Sandhoff disease were detected. They presented with exaggerated startle response to acoustic stimuli, seizures, optic atrophy and retinal cherry red spots in addition to psychomotor retardation. One case of Sandhoff disease had hepatosplenomegaly and skeletal deformities.
Similar content being viewed by others
References
Tay W. Symmetrical changes in the region of the yellow spot in each eye of an infant.Trans Opthalmol Soc UK 1881; 1: 155–157.
Sachs B. A familial form of idiocy, generally fatal associated with early blindness.J. Nerv Ment Dis 1886; 21: 475.
Klenk E. On gangliosides.Am J Dis Child 1959; 711–714.
Svennerholm L. The chemical nature of normal human brain and Tay-Sachs gangliosides,Biochem Biophy Res Commun 1962; 9: 436–441.
Okada S, O’Brien JS. Tay-Sachs disease: Generalised absence of a beta-D-N-acetylhexosamindase component.Science 1969; 165: 698–700.
Kolodny EH. The GM2 Gangliosidoses, In:The Molecular and Genetic Basis of Neurologic Disease, Eds.: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, Kunke LM, Butterworth-Heinemann, Boston, 1993; 532–538.
Scriver CR, Beaudet AC, Sly WL, Valle D,The Metabolic Basis of Inherited Disease, 6th ed. USA: McGraw-Hill, Inc. 1989; 1807–1835.
Kremer RD, Boldini CD, Capra AP. Sandhoff disease: 36 cases from Cardoba, Argentina.J Inher Metab Dis 1985; 8: 46.
Lowden JA, Ives EJ, Keene DL. Carrier detection in Sandhoff disease.Am J Hum Genet 1978; 30: 38–40.
Savliwala AS, Gautami Naik, Barucha BA, Khare RD, Kumta NB, Sandhoff disease-GM2 gangliosidosis type 2.Indian Pediatr 1983; 20: 134–137.
Kumta NB, Irani SF, Bhide AR et al. Hexosaminidase A deficiency.Medical genetics in India Eds. I. C. Verma, Auroma Enterprises, Pondicherry, 1978; 1: 97–102.
Vardkar AM, Mahale SD, Suchak RH et al. GM2 gangliosidosis type 2.Indian Pediatr 1983; 5: 302–304.
Rao BSS, Padmashree TS, Sudarshan NM, Jayasimha N. Utility of biochemical and genetic investigations in the diagnosis and management of some forms of mental retardation with a report of work carried out in NIMHANS, Bangalore.Biol Mental Retardation 1987; 3: 37–47.
O’Brien JS, OKada S, Chen A, Fillerup DL, Tay-Sachs disease: Detection of heterozygotes and homozygotes by serum hexosaminidase assay.New Eng J Med 1970; 289: 15–20.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Christopher, R., Rangaswamy, G.R. & Shetty, K.T. GM2 gangliosidoses: A review of cases confirmed by β-N-acetylhexosaminidase assay. Indian J Pediatr 62, 479–483 (1995). https://doi.org/10.1007/BF02755071
Issue Date:
DOI: https://doi.org/10.1007/BF02755071